Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study
Primary Purpose
Head and Neck Cancer
Status
Recruiting
Phase
Locations
Italy
Study Type
Observational
Intervention
Lymph Node Yield (LNY) and Lymph Node Ratio (LNR)
Sponsored by
About this trial
This is an observational trial for Head and Neck Cancer
Eligibility Criteria
Inclusion Criteria:
- patients affected by oral cavity, oropharynx, larynx squamous cell carcinoma
Exclusion Criteria:
- patients affected by other cancers
Sites / Locations
- Oreste IoccaRecruiting
Arms of the Study
Arm 1
Arm Type
Arm Label
patients undergoing neck dissection
Arm Description
all patients undergoing neck dissection
Outcomes
Primary Outcome Measures
Optimal cut-off value for 5 year Overall Survival
Secondary Outcome Measures
Full Information
NCT ID
NCT03534778
First Posted
May 11, 2018
Last Updated
April 17, 2019
Sponsor
University of Roma La Sapienza
1. Study Identification
Unique Protocol Identification Number
NCT03534778
Brief Title
Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study
Official Title
Prognostic Significance of Lymph Node Yield and Lymph Node Ratio in Patients Affected by Squamous Cell Carcinoma of the Oral Cavity, Hypopharynx and Larynx: a Prospective, Multicenter Observational Study
Study Type
Observational
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
January 1, 2022 (Anticipated)
Study Completion Date
January 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Roma La Sapienza
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
It is still unclear if Lymph Node Yield (LNY) and Lymph Node Ratio (LNR) may have a prognostic role in patients affected by carcinoma of the oral cavity and the oropharynx. Only retrospective studies are available. For this reason, this prospective, multi center, observational study should provide indications in this regard. Proper stratification by patients characteristics will allow to understand if LNY and LNR may enter in the future TNM staging system
Detailed Description
Lymph node involvement is a fundamental prognostic factor in head and neck squamous cell carcinoma (SCC). Lymph node yield (LNY), which is the number of lymph nodes retrieved after neck dissection, and lymph node ratio (LNR), which is the ratio of positive lymph nodes out of the total removed, are measurable indicators that may have the potential to be used as prognostic factors. The present study is designed to define the exact role of LNY and LNR regarding the overall and specific survival of patients affected by oral cavity and oropharyngeal SCC.
This is a multicenter study involving tertiary care referral centers in Europe and North America. Patients affected by oral cavity, HPV+ and HPV- oropharyngeal SCC undergoing neck dissection will be consecutively enrolled and followed-up for up to 5 years. Patients and disease characteristic will be properly recorded and centrally analyzed. The primary end-point is to define reliable cut off- values for LNY and LNR which may serve as prognosticators of survival. This will be achieved through the use of ROC curves. Secondary outcomes will be the Overall survival (OS), Disease Specific Survival (DSS), and Progression Free Survival Hazard Ratios (HR) at 2-, 3- and 5 years, which will be evaluated through the Kaplan-Meier method and the difference in survival attested by the log-rank test. Univariate and multivariate analysis will be performed to understand the association of various outcomes with LNY and LNR.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer
7. Study Design
Enrollment
350 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
patients undergoing neck dissection
Arm Description
all patients undergoing neck dissection
Intervention Type
Diagnostic Test
Intervention Name(s)
Lymph Node Yield (LNY) and Lymph Node Ratio (LNR)
Intervention Description
LNY and LNR will be examined after neck dissection
Primary Outcome Measure Information:
Title
Optimal cut-off value for 5 year Overall Survival
Time Frame
5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients affected by oral cavity, oropharynx, larynx squamous cell carcinoma
Exclusion Criteria:
patients affected by other cancers
Study Population Description
Patients affected by oral or oropharyngeal squamous cell carcinoma who undergo upfront surgery and neck dissection
Sampling Method
Non-Probability Sample
Facility Information:
Facility Name
Oreste Iocca
City
Milano
State/Province
MI
ZIP/Postal Code
20138
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
oreste iocca
Phone
3398540121
Email
oreste.iocca86@gmail.com
12. IPD Sharing Statement
Citations:
PubMed Identifier
30723839
Citation
Iocca O, Farcomeni A, De Virgilio A, Di Maio P, Golusinski P, Malvezzi L, Pellini R, Golusinski W, Rassekh CH, Spriano G. Prognostic significance of lymph node yield and lymph node ratio in patients affected by squamous cell carcinoma of the oral cavity and oropharynx: Study protocol for a prospective, multicenter, observational study. Contemp Clin Trials Commun. 2019 Jan 14;14:100324. doi: 10.1016/j.conctc.2019.100324. eCollection 2019 Jun.
Results Reference
derived
Learn more about this trial
Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study
We'll reach out to this number within 24 hrs